Skip to search formSkip to main contentSkip to account menu

CY 216

Known as: CY-216, CY216 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Sixty-one consecutive patients were enrolled in a randomized, controlled trial of thromboprophylaxis with a low molecular weight… 
1993
1993
Summary. This study compares the ability of unfractionated heparin (UH) and of three low molecular weight heparins (LMWHs) to… 
1993
1993
The inhibiting effect of standard heparin, CY216 and the ATIII-binding synthetic pentasaccharide on extrinsic and intrinsic… 
1992
1992
In 14 patients undergoing chronic hemodialysis, we investigated the safety and efficacy of the low molecular fragment (CY-216) in… 
1992
1992
Low-molecular-weight heparin subfractions more specifically inhibit factor Xa than thrombin, and they may have advantages over… 
1992
1992
Three fractions of the low molecular weight heparin CY216 (fraxiparin, mean molecular weight [MMW] 5,090), with MMWs of… 
1991
1991
Low molecular weight (LMW) heparin preparations have unknown distributions of ATIII-binding material, so mean molecular weights… 
1990
1990
Ninety consecutive outpatients with acute proximal and/or distal deep-vein thrombosis (DVT), as shown by phlebography, were… 
Highly Cited
1985
Highly Cited
1985
The efficacy and safety of a low‐molecular‐weight (LMW) heparin fraction in preventing postoperative venous thrombo‐embolism, was…